NIH sponsored three influenza trials; India's BCG Vaccine Laboratory will swing back into action;

@AlisonBFierce: GBI Research forecasts that the global pediatric vaccines market will hit $24.3 billion by 2017. More | Follow @AlisonBFierce

> The Bill & Melinda Gates Foundation recognized Margarida Matsinhe with a $250,000 award for her work in developing new approaches to improve vaccine delivery logistics in Mozambique. Story

> The European Union will fund Project RAPSODI, an international consortium of 7 partners from leishmaniasis-endemic countries working toward developing a vaccine to thwart the disease. News

> Investissement Québec agreed to a three-year extension of a $15.3 million loan to Medicago, which will help Medicago develop plant-based VLP vaccines. Release

> NIH sponsored three clinical trials seeking to find more effective influenza treatments. More

> Vaximm reported positive top-line data from its first oral cancer vaccine trial. Release

And Finally... India's BCG Vaccine Laboratory, shut down nearly four years ago for not complying with current good manufacturing practices, will again launch into production of a tuberculosis vaccine after receiving final clearance from a regulatory agency. Report

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.